Share on StockTwits

Mednax (NYSE:MD) Insider Karl B. Wagner sold 80,000 shares of Mednax stock in a transaction dated Wednesday, July 30th. The stock was sold at an average price of $60.00, for a total value of $4,800,000.00. Following the sale, the insider now directly owns 130,195 shares of the company’s stock, valued at approximately $7,811,700. The sale was disclosed in a filing with the SEC, which is available at this link.

MD has been the subject of a number of recent research reports. Analysts at Susquehanna initiated coverage on shares of Mednax in a research note on Tuesday, July 8th. They set a “positive” rating on the stock. Analysts at Dougherty & Co raised their price target on shares of Mednax from $63.00 to $66.00 in a research note on Monday, May 5th. They now have a “buy” rating on the stock. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $76.25.

Shares of Mednax (NYSE:MD) traded down 3.13% on Friday, hitting $57.33. 1,120,584 shares of the company’s stock traded hands. Mednax has a 52 week low of $48.115 and a 52 week high of $64.51. The stock has a 50-day moving average of $58.17 and a 200-day moving average of $58.68. The company has a market cap of $5.680 billion and a price-to-earnings ratio of 20.69.

Mednax (NYSE:MD) last posted its quarterly earnings results on Thursday, July 31st. The company reported $0.79 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.78 by $0.01. The company had revenue of $595.54 million for the quarter, compared to the consensus estimate of $603.00 million. During the same quarter in the prior year, the company posted $1.37 earnings per share. The company’s quarterly revenue was up 12.6% on a year-over-year basis. Analysts expect that Mednax will post $3.15 EPS for the current fiscal year.

MEDNAX, Inc (NYSE:MD) is a provider of physician services, including newborn, maternal-fetal, pediatric subspecialties and anesthesia care.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.